Acurx Pharmaceuticals

(NASDAQ) ACXP

Current Price$1.98

Market Cap$8.51M

Since IPO (2021)-99%

5 YearN/A

1 Year-74%

1 Month+1%

Acurx Pharmaceuticals Financials at a Glance

Market Cap

$8.51M

Revenue (TTM)

$0.00

Net Income (TTM)

-$7.50M

EPS (TTM)

-$4.40

P/E Ratio

-0.45

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.98

Volume

62,196

Open

$1.96

Price

$1.98

Volume

62,196

Open

$1.96

Previous Close

$1.98

Daily Range

$1.94 - $2.01

52-Week Range

$1.33 - $21.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.98

Volume

62,196

Open

$1.96

Previous Close

$1.98

Daily Range

$1.94 - $2.01

52-Week Range

$1.33 - $21.00

ACXP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Acurx Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David P. Luci, CPA

Website

www.acurxpharma.com

Headquarters

Staten Island, NY 10305, US

ACXP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-161%

Return on Capital

-1%

Return on Assets

-79%

Earnings Yield

-2.22%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.51M

Shares Outstanding

4.30M

Volume

62.20K

Avg. Volume

3.10M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$8.09M

EBITDA

-$8.09M

Operating Cash Flow

-$6.79B

Capital Expenditure

$0.00

Free Cash Flow

-$6.79B

Cash & ST Invst.

$7.56B

Total Debt

$0.00

Acurx Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$8.51M

N/A

Market Cap/Employee

$2.13M

N/A

Employees

N/A

Net Income

-$1.68M

+21.8%

EBITDA

-$1.72M

N/A

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$9.25M

+99.3%

Accounts Receivable

$56.31K

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-78.60%

N/A

Return on Invested Capital

-1.09%

N/A

Free Cash Flow

-$1.41M

+31.4%

Operating Cash Flow

-$1.41M

+31.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

INABIN8bio, Inc.

INABIN8bio, Inc.$1.87+3.89%

BCLIBrainstorm Cell Therapeutics Inc.

BCLIBrainstorm Cell Therapeutics Inc.$0.75+4.02%

APVOAptevo Therapeutics Inc.

APVOAptevo Therapeutics Inc.$4.91-1.80%

CELZCreative Medical Technology Holdings, Inc.

CELZCreative Medical Technology Holdings, Inc.$2.25-0.22%

APREAprea Therapeutics, Inc.

APREAprea Therapeutics, Inc.$0.89-4.07%

BCDABioCardia, Inc.

BCDABioCardia, Inc.$0.93+1.44%

KPRXKiora Pharmaceuticals, Inc.

KPRXKiora Pharmaceuticals, Inc.$2.68-5.30%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$114.68-0.05%

SPCEVirgin Galactic

SPCEVirgin Galactic$6.18+0.36%

FFord Motor Company

FFord Motor Company$17.44+0.05%

ONDSOndas

ONDSOndas$13.22-0.00%

NOKNokia

NOKNokia$14.84-0.03%

SMCISuper Micro Computer

SMCISuper Micro Computer$46.09+0.12%

PLTRPalantir Technologies

PLTRPalantir Technologies$156.54+0.09%

Questions About ACXP

What is the current price of Acurx Pharmaceuticals?

Acurx Pharmaceuticals is trading at $1.98 per share.

What is the 52-week range for Acurx Pharmaceuticals?

Over the past 52 weeks, Acurx Pharmaceuticals has traded between $1.33 and $21.00.

How much debt does Acurx Pharmaceuticals have?

As of the most recent reporting period, Acurx Pharmaceuticals reported total debt of $0.00.

How much cash does Acurx Pharmaceuticals have on hand?

Acurx Pharmaceuticals reported $9.25M in cash and cash equivalents in its most recent financial results.

What is Acurx Pharmaceuticals’s dividend yield?

Acurx Pharmaceuticals does not currently have a dividend yield.

Acurx Pharmaceuticals

Acurx Pharmaceuticals Financials at a Glance

ACXP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Acurx Pharmaceuticals

ACXP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Acurx Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ACXP

What is the current price of Acurx Pharmaceuticals?

What is the 52-week range for Acurx Pharmaceuticals?

How much debt does Acurx Pharmaceuticals have?

How much cash does Acurx Pharmaceuticals have on hand?

What is Acurx Pharmaceuticals’s dividend yield?

Premium Investing Services